Precision Bio-Interface

Plasma-Enhanced Biomaterials for Oncology

PlasmOnCo engineers advanced biomaterial matrices using cold atmospheric plasma, enabling targeted therapeutic delivery and microenvironment modulation to enhance cancer therapy.

Our technology allows to generate biologically active species within biomaterials aimed to be injected or implanted directly in the disease site, with minimal associated toxicity. Our solution is 100% biocompatible and biodegradable.

Validated Performance

Quantitative Scientific Metrics

100%

Filling of the resected tumor site for a Personalized medicine

~90%

Healthy cells viability to ensure selectivity

6-fold

Reduction of the chemotherapy dosis

From ~75 to 25%

Relapses demonstrated in in vivo studies

— SCIENTIFIC EVIDENCE

The Science Behind Us

Explore our body of peer-reviewed scientific articles in the fields of plasma medicine, biomaterials and oncology and cold plasma, validating PlasmOnCo's plasma-engineered technology.

JOURNAL ARTICLES

Peer-Reviewed Manuscripts

Key publications from the PlasmaMED Lab Research Group at UPC towards cold atmospheric plasma interaction with hydrogel-based biomaterials, localized RONS release dynamics, biological response and microenvironment modulation.

• M. Živanić, A. Espona-Noguera, A. Privat Maldonado, P. Matušů, F. Tampieri, M.P. Ginebra, A. Lin, E. Smits, A. Bogaerts, C. Canal. Plasma-Treated Hydrogel for Combined RONS and Chemotherapy Delivery: A Proof-of-Concept In Ovo. Adv. Funct. Mater., e02779 (2025)

• J. Tornin, C. Labay, F. Tampieri, M.P. Ginebra, C. Canal. Evaluation of the effects of cold atmospheric plasma and plasma-treated liquids in cancer cell cultures, Nature Protocols, 16, 2826 (2021)

• C. Labay, M. Roldán, F. Tampieri, A. Stancampiano, P. Escot Bocanegra, M.-P. Ginebra, C. Canal, Enhanced Generation of Reactive Species by Cold Plasma in Gelatin Solutions for Selective Cancer Cell Death, ACS Appl. Mater. Interfaces, 12, 42, 47256 (2020)

• M. Živanić, A. Espona-Noguera, H. Verswyvel, E. Smits, A. Bogaerts, A. Lin, C. Canal. Injectable Plasma-Treated Alginate Hydrogel for Oxidative Stress Delivery to Induce Immunogenic Cell Death in Osteosarcoma, Adv. Funct. Mater., 34, 2312005 (2024)

• C. Labay, I. Hamouda, F. Tampieri, M.P. Ginebra, C. Canal. Production of reactive species in alginate hydrogels for cold atmospheric plasma-based therapies. Scientific Reports, 9, 16160 (2019)

Advance Oncology Research

Collaborate with our team to explore the potential of plasma-engineered biomaterials in your next breakthrough.

Our Engineered Approach

Translational Biomaterial Process

01
02
03
04

Plasma Treatment

Molecular Bio-Functionalization

Targeted Localized Implantation

Local Drug Release

Cold atmospheric plasma functionalization precisely implants reactive oxygen and nitrogen species (RONS) into hydrogel polymer networks.

Our process integrates specific biomolecules, programming the scaffold for targeted cellular interaction and therapeutic response.

Engineered scaffolds are designed for high-precision localized delivery, minimizing systemic exposure and maximizing therapeutic efficacy.

Customizable degradation rates ensure sustained and controlled release kinetics, perfectly matched to tumor histology and treatment protocols.